Shopping Cart 0
Cart Subtotal
AED 0

North America Hemodialysis and Peritoneal Dialysis Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 9175

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 11744
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

North America hemodialysis and peritoneal dialysis market is expected to reach USD 53,741.5 million by 2025 from USD 32,324.9 million in 2017, at a CAGR of 6.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the market are increased number of ESRD patients. The hemodialysis and peritoneal dialysis market in the North America region is leading in U.S.

The key market players for North America hemodialysis and peritoneal dialysis market are listed below:

Fresenius

DaVita Inc.

Baxter,

B. Braun Melsungen AG,

Diaverum,

Nipro, Nxstage Medical, Inc.,

Nikkiso Co., Ltd.,

Mar Cor Purification,

Asahi Kasei Medical Co., Ltd,

Rockwell Medical,

Medtronic,

Dialifegroup,

JMS Co.Ltd.,

Atlantic Biomedical,

3M,

Allmed Medical Care Holdings Limited.,

Isopure Corp.,

C. R. Bard, Inc.

The market is further segmented into:

Type

Products & Services

Modality

Hemodialysis Water Treatment System

End-user

The North America hemodialysis and peritoneal dialysis market is segmented on the basis of type, biopsy technique and end users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The North America hemodialysis & peritoneal dialysis market is segmented on the basis of type into hemodialysis and peritoneal dialysis. In 2018, The Hemodialysis Market is expected to dominate the market with 75.2% market share and is expected to reach USD 39,981.6 million by 2025, growing at a CAGR of 6.5% in the forecast period 2018 to 2025.

The North America hemodialysis market is segmented on the basis of product services into machine, consumables, and services. In 2018, the hemodialysis machine market is expected to dominate market with 41.2% market share and is expected to reach USD 16,954.7 million by 2025, growing at a CAGR of 6.9% in the forecast period 2018 to 2025. The machines are further sub segmented into center-use hemodialysis machines and home-use hemodialysis machines. The consumables are further sub segmented into dialyzers, bloodlines, hemodialysis concentrates and others. Dialyzers are further sub-segmented on the basis of material type into synthetic and cellulose based; on the basis of flux type into high-flux and low-flux and on the basis of by hemodialysis access management products into AV fistula, arteriovenous grafts, tunneled hemodialysis catheter and temporary hemodialysis catheter. Hemodialysis concentrates are further sub-segmented into- alkaline and acidic. Services are further sub-segmented into in-center hemodialysis services and home hemodialysis services.

The North America hemodialysis water treatment system Market is segmented on the basis of type into central water disinfection systems and portable water disinfection systems. In 2018, portable water disinfection systems market is expected to dominate market with 60.6% market share and is expected to reach USD 24,784.9 million by 2025, growing at a CAGR of 6.8% in the forecast period 2018 to 2025. Central water disinfection systems are further sub-segmented into chemical disinfection systems, heat disinfection systems, accessories.

The North America hemodialysis market is segmented on the basis of modality into conventional long-term, short daily and nocturnal. In 2018, conventional long-term market is expected to dominate market with 42.1% market share and is expected to reach USD 17,289.5 million by 2025, growing at a CAGR of 6.9% in the forecast period 2018 to 2025.

The North America peritoneal dialysis market is segmented on the basis of products and services into concentrates, machines, catheters, transfer sets, services and others. In 2018, peritoneal machine market is expected to dominate market with 31.2% market share and is expected to reach USD 4,644.8 million by 2025, growing at a CAGR of 8.3% in the forecast period 2018 to 2025. The catheters are further sub-segmented into short-term catheters and long term catheters.

The North America peritoneal dialysis market is segmented on the basis of modality into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. In 2018, continuous ambulatory dialysis market is expected to dominate market with 67.8% market share and is expected to reach USD 9,478.7 million by 2025, growing at a CAGR of 7.4% in the forecast period 2018 to 2025.

The North America hemodialysis & peritoneal dialysis market is segmented on the basis of end-user into hospitals, dialysis centers and home care settings. In 2018, dialysis centers market is expected to dominate market with 57.6% market share and is expected to reach USD 31,293.7 million by 2025, growing at a CAGR 6.8% in the forecast period 2018 to 2025. The home care settings are further sub-segmented into peritoneal dialysis and home dialysis.

Based on geography, the North America hemodialysis and peritoneal dialysis market is segmented into geographical regions, such as,

U.S.,

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America hemodialysis and peritoneal dialysis market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Table Of Content

Scope

Table Of Contents

1. Introduction 50

1.1. Objectives Of The Study 50

1.2. Market Definition 50

1.3. Overview Of North America Hemodialysis & Peritoneal Dialysis Market 50

1.4. Currency And Pricing 51

1.5. Limitation 52

1.6. Markets Covered 52

2. Market Segmentation 55

2.1. Markets Covered 55

2.2. Geographic Scope 56

2.3. Years Considered For The Study 57

2.4. Currency And Pricing 57

2.5. Research Methodology 58

2.6. Primary Interviews With Key Opinion Leaders 61

2.7. Secondary Sources 62

2.8. Assumptions 62

3. Market Overview 63

3.1. Drivers 65

3.1.1. Increased Number Of End Stage Renal Disease (Esrd) Patients 65

3.1.2. Increased Prevalance Of Diabetes And Hypertension 66

3.1.3. Preferance Of Patients For Dialysis Treatment Over Kidney Transplant 67

3.1.4. Rising Geriatric Population 68

3.1.5. R&D Investemnts In For Innovating Dialysis Products 68

3.1.6. Technological Advancements In The Products 70

3.1.7. Favorable Reimbursement Policy 71

3.2. Restraints 72

3.2.1. Risks Associated With The Treatment 72

3.2.2. Stringent Regulatory Framework 73

3.3. Opportunities 74

3.3.1. Increased Demand Of Homecare Settings For Dialysis Treatment 74

3.3.2. Low Cost And User Friendly Products Innovated 75

3.4. Challenges 76

3.4.1. Product Recalls 76

4. Executive Summary 77

5. Premium Insights 81

6. North America Hemodialysis & Peritoneal Dialysis Market, By Type 88

6.1. Overview 89

6.2. Hemodialysis 91

6.3. Peritoneal Dialysis 92

7. North America Hemodialysis Market, By Products And Services 93

7.1. Overview 94

7.2. Machines 96

7.2.1. Center-Use Hemodialysis Machines 98

7.2.2. Home-Use Hemodialysis Machines 98

7.3. Consumables 99

7.3.1. Dialyzers 101

7.3.1.1. Dialyzers Market, By Material Type 101

7.3.1.2. Dialyzers Market, By Flux Type 102

7.3.1.3. Hemodialysis Access Management Products Market, By Type 103

7.3.2. Bloodlines 104

7.3.3. Hemodialysis Concentrates 104

7.3.3.1. Alkaline 105

7.3.3.2. Acidic 105

7.3.4. Others 105

7.4. Services 106

7.4.1. In-Center Hemodialysis Services 107

7.4.2. Home Hemodialysis Services 107

8. North America Hemodialysis Market, By Modality 108

8.1. Overview 109

8.2. Conventional Long-Term 111

8.3. Nocturnal 112

8.4. Short Daily 113

9. North America Peritoneal Market, By Products And Services 114

9.1. Overview 115

9.2. Machines 117

9.3. Catheters 118

9.3.1. Short Term Catheters 119

9.3.2. Long Term Catheters 119

9.4. Transfer Sets 120

9.5. Concentrates 121

9.6. Services 122

9.7. Others 123

10. North America Peritoneal Dialysis Market, By Modality 124

10.1. Overview 125

10.2. Continuous Ambulatory Peritoneal Dialysis 127

10.3. Automated Peritoneal Dialysis 128

11. North America Hemodialysis Water Treatment Systems Market,

By Type 129

11.1. Overview 130

11.2. Portable Water Disinfection Systems 132

11.3. Central Water Disinfection Systems 133

11.3.1. Heat Disinfection Systems 134

11.3.2. Chemical Disinfection Systems 135

11.3.3. Accessories 135

12. North America Hemodialysis And Peritoneal Dialysis Market,

By End User 136

12.1. Overview 137

12.2. Dialysis Centers 139

12.3. Hospitals 140

12.4. Home Care Settings 141

12.4.1. Peritoneal Dialysis 142

12.4.2. Home Hemodialysis 142

13. North America Hemodialysis And Peritoneal Dialysis Market,

By Geography 143

13.1. Overview 144

13.2. North America 151

13.2.1. U.S. 166

13.2.2. Canada 175

13.2.3. Mexico 184

14. North America Hemodialysis And Peritoneal Dialysis Market, Company Landscape 457

14.2. Company Share Analysis: North America 458

15. Company Profile 461

15.1. Davita Inc. 461

15.1.1. Company Overview 461

15.1.2. Davita, Inc.: Revenue Analysis 462

15.1.3. Product Portfolio 463

15.1.4. Recent Developments 464

15.2. Diaverum 465

15.2.1. Company Overview 465

15.2.2. Diaverum: Company Snapshot 465

15.2.3. Product Portfolio 466

15.2.4. Recent Developments 466

15.3. Nipro 467

15.3.1. Company Overview 467

15.3.2. Nipro Corporation: Revenue Analysis 468

15.3.3. Product Portfolio 469

15.3.4. Recent Developments 470

15.4. Nxstage Medical, Inc. 471

15.4.1. Company Overview 471

15.4.2. Nxstage Medical, Inc.: Company Snapshot 472

15.4.3. Product Portfolio 473

15.4.4. Recent Developments 474

15.5. Nikkiso Co., Ltd. 476

15.5.1. Company Overview 476

15.5.2. Nikkiso Co., Ltd.: Revenue Analysis 477

15.5.3. Product Portfolio 478

15.5.4. Recent Developments 478

15.6. Atlantic Biomedical Pvt. Ltd 479

15.6.1. Company Overview 479

15.6.2. Atlantic Biomedical Pvt. Ltd: Company Snapshot 479

15.6.3. Product Portfolio 480

15.6.4. Recent Developments 480

15.7. 3M 481

15.7.1. Company Overview 481

15.7.2. 3M: Company Snapshot 481

15.7.3. Product Portfolio 482

15.7.4. Recent Developments 482

15.8. C.R. Bard Inc. 483

15.8.1. Company Overview 483

15.8.2. C. R. Bard Inc.: Revenue Analyses 483

15.8.3. Product Portfolio 484

15.8.4. Recent Developments 484

15.9. Allmed Medical Co., Limited 485

15.9.1. Company Overview 485

15.9.2. Allmed Medical Co., Ltd: Company Snapshot 485

15.9.3. Product Portfolio 486

15.9.4. Recent Developments 486

15.10. Isopure Corp. 487

15.10.1. Company Overview 487

15.10.2. Isopure Corp : Company Snapshot 487

15.10.3. Product Portfolio 488

15.10.4. Recent Developments 488

15.11. Cvp Medical Technology Co., Ltd 489

15.11.1. Company Overview 489

15.11.2. Cvp Medical Technology Co., Ltd.: Company Snapshot 489

15.11.3. Product Portfolio 490

15.11.4. Recent Developments 490

15.12. Mar Cor Purification Inc. 491

15.12.1. Company Overview 491

15.12.2. Mar Cor Purification: Company Snapshot 491

15.12.3. Product Portfolio 492

15.12.4. Recent Developments 494

15.13. Baxter 495

15.13.1. Company Overview 495

15.13.2. Baxter: Company Snapshot 495

15.13.3. Product Portfolio 496

15.13.4. Recent Developments 497

15.14. Medtronic 498

15.14.1. Company Overview 498

15.14.2. Medtronic: Rvenue Analysis 498

15.14.3. Product Portfolio 499

15.14.4. Recent Developments 499

15.15. Fresenius Group 500

15.15.1. Company Overview 500

15.15.2. Fresenius Group: Revenue Analysis 500

15.15.3. Product Portfolio 501

15.15.4. Recent Developments 502

15.16. B.Braun 503

15.16.1. Company Overview 503

15.16.2. B.Braun.: Company Snapshot 503

15.16.3. Product Portfolio 504

15.16.4. Recent Developments 504

15.17. Asahi Kasei Corporation 505

15.17.1. Company Overview 505

15.17.2. Asahi Kasei Corporation: Revenue Analysis 506

15.17.3. Product Portfolio 506

15.17.4. Recent Developments 507

15.18. Rockwell Medical, Inc. 508

15.18.1. Company Overview 508

15.18.2. Rockwell Medical, Inc.: Revenue Analysis 508

15.18.3. Product Portfolio 508

15.18.4. Recent Developments 509

15.19. Dialife Group 510

15.19.1. Company Overview 510

15.19.2. Dialife Group: Company Snapshot 510

15.19.3. Product Portfolio 511

15.19.4. Recent Developments 511

15.20. Jms Co., Ltd. 512

15.20.1. Company Overview 512

15.20.2. Jms Co., Ltd.: Company Snapshot 512

15.20.3. Product Portfolio 512

15.20.4. Recent Developments 513

16. Related Reports 515


List Of Figure

Figures List

Figure 1 North America Hemodialysis & Peritoneal Dialysis Market : Segmentation 55

Figure 2 North America Hemodialysis & Peritoneal Dialysis Market :

Data Triangulation 58

Figure 3 North America Hemodialysis & Peritoneal Dialysis Market :

Research Snapshot 59

Figure 4 North America Hemodialysis & Peritoneal Dialysis Market :

Bottom Up Approach 60

Figure 5 North America Hemodialysis & Peritoneal Dialysis Market :

Top Down Approach 60

Figure 6 North America Hemodialysis & Peritoneal Dialysis Market :

Interview Demographics 61

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of

North America Hemodialysis & Peritoneal Dialysis Market 64

Figure 8 North America Hemodialysis & Peritoneal Dialysis Market : Segmentation 79

Figure 9 North America Is Expected To Dominate The Market For Hemodialysis & Peritoneal Dialysis And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 80

Figure 10 Increasing Number Of Esrd Patients Are The Factors And R&D Investments For Innovating Dialysis Products Are Expected To Drive The Market For Hemodialysis & Peritoneal Dialysis Market In The Forecast Period 2018 To 2025 81

Figure 11 Hemodialysis Is Expected To Account For The Largest Share Of The North America Hemodialysis & Peritoneal Dialysis Market In 2018 & 2025 82

Figure 12 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hemodialysis And Peritoneal Dialysis Manufacturers In The Forecast Period From 2018 To 2025 83

Figure 13 Diabetes Prevalence In Different Countries In 2017 (% Of Population Ages Between 20 To 79) 84

Figure 14 Prevalent Counts Of Reported Esrd In U.S. (2001-2015) 85

Figure 15 Various Causes Of Esrd In U.S. (2010 & 2015) 86

Figure 16 Number Of Diabetic Patients, By Region In 2017 (Million) 87

Figure 17 North America Hemodialysis & Peritoneal Dialysis Market: By Type, 2017 89

Figure 18 North America Hemodialysis Market : By Products & Services, 2017 94

Figure 19 North America Hemodialysis Market: By Modality, 2017 109

Figure 29 North America Hemodialysis And Peritoneal Dialysis Market : Snapshot (2017) 152

Figure 30 North America Hemodialysis And Peritoneal Dialysis Market:

By Country (2017) 153

Figure 31 North America Hemodialysis And Peritoneal Dialysis Market:

By Country (2018) 154

Figure 32 North America Hemodialysis And Peritoneal Dialysis Market,

By Country (2017 & 2025) 155

Figure 33 North America Hemodialysis And Peritoneal Dialysis Market,

By Product Type (2018 & 2025) 156

Figure 55 North America Hemodialysis And Peritoneal Dialysis Market: Company Share 2017 (%) 458


List Of Table

TABLE 1 FRESENIUS MEDICAL CARE AG & CO. KGAA, R&D ACTIVITIES 69

TABLE 2 DAVITA INC.: GROWTH OF U.S. DIALYSIS OPERATIONS BY NUMBER OF DIALYSIS CENTERS 69

TABLE 3 NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY TYPE,

2016-2025 (USD MILLION) 90

TABLE 4 NORTH AMERICA HEMODIALYSIS MARKET, BY REGION, 2016-2025 (USD MILLION) 91

TABLE 5 NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY REGION,

2016-2025 (USD MILLION) 92

TABLE 6 NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCTS & SERVICES,

2016-2025 (USD MILLION) 95

TABLE 7 NORTH AMERICA HEMODIALYSIS, MACHINES MARKET, BY TYPE

2016-2025 (USD MILLION) 96

TABLE 8 NORTH AMERICA HEMODIALYSIS MACHINES MARKET, BY REGION,

2016-2025 (USD MILLION) 97

TABLE 9 NORTH AMERICA HEMODIALYSIS CONSUMABLES MARKET, BY TYPE,

2016-2025 (USD MILLION) 99

TABLE 10 NORTH AMERICA HEMODIALYSIS CONSUMABLES MARKET, BY REGION,

2016-2025 (USD MILLION) 100

TABLE 11 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 101

TABLE 12 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 102

TABLE 13 NORTH AMERICA HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 104

TABLE 14 NORTH AMERICA HEMODIALYSIS SERVICES MARKET, BY TYPE,

2016-2025 (USD MILLION) 106

TABLE 15 NORTH AMERICA HEMODIALYSIS SERVICES MARKET, BY REGION,

2016-2025 (USD MILLION) 107

TABLE 16 NORTH AMERICA HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 110

TABLE 17 NORTH AMERICA CONVENTIONAL LONG-TERM HEMODIALYSIS MARKET, BY REGION, 2016-2025 (USD MILLION) 111

TABLE 18 NORTH AMERICA NOCTURNAL HEMODIALYSIS MARKET , BY REGION,

2016-2025 (USD MILLION) 112

TABLE 19 NORTH AMERICA SHORT DAILY HEMODIALYSIS MARKET, BY REGION,

2016-2025 (USD MILLION) 113

TABLE 41 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY COUNTRY, 2016-2025 (USD MILLION) 157

TABLE 42 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 157

TABLE 43 NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 158

TABLE 44 NORTH AMERICA HEMODIALYSIS MACHINE MARKET, BY TYPE,

2016-2025 (USD MILLION) 158

TABLE 45 NORTH AMERICA HEMODIALYSIS CONSUMABLES MARKET, BY TYPE,

2016-2025 (USD MILLION) 159

TABLE 46 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET,

BY MATERIAL TYPE, 2016-2025 (USD MILLION) 159

TABLE 47 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET,

BY FLUX TYPE, 2016-2025 (USD MILLION) 160

TABLE 48 NORTH AMERICA HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKETBY TYPE, 2016-2025 (USD MILLION) 160

TABLE 49 NORTH AMERICA HEMODIALYSIS CONCENTRATES MARKET,

BY TYPE, 2016-2025 (USD MILLION) 161

TABLE 50 NORTH AMERICA HEMODIALYSIS SERVICES MARKET,

BY TYPE, 2016-2025 (USD MILLION) 161

TABLE 51 NORTH AMERICA HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 162

TABLE 52 NORTH AMERICA HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 162

TABLE 53 NORTH AMERICA HEMODIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 163

TABLE 54 NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2016-2025 (USD MILLION) 163

TABLE 55 NORTH AMERICA PERITONEAL DIALYSIS CATHETERS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 164

TABLE 56 NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 164

TABLE 57 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 165

TABLE 58 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 165

TABLE 59 U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 166

TABLE 60 U.S. HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 166

TABLE 61 U.S. HEMODIALYSIS MACHINE MARKET, BY TYPE, 2016-2025 (USD MILLION) 167

TABLE 62 U.S. HEMODIALYSIS CONSUMABLES MARKET,BY TYPE,

2016-2025 (USD MILLION) 167

TABLE 63 U.S. HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 168

TABLE 64 U.S. HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 168

TABLE 65 U.S. HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKET

BY TYPE, 2016-2025 (USD MILLION) 169

TABLE 66 U.S. HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 169

TABLE 67 U.S. HEMODIALYSIS SERVICES MARKET, BY TYPE, 2016-2025 (USD MILLION) 170

TABLE 68 U.S. HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 170

TABLE 69 U.S. HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 171

TABLE 70 U.S. HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 171

TABLE 71 U.S. PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES,

2016-2025 (USD MILLION) 172

TABLE 72 U.S. PERITONEAL DIALYSIS CATHETERS MARKET, , BY TYPE,

2016-2025 (USD MILLION) 172

TABLE 73 U.S. PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 173

TABLE 74 U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 173

TABLE 75 U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 174

TABLE 76 CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 175

TABLE 77 CANADA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 175

TABLE 78 CANADA HEMODIALYSIS MACHINE MARKET, BY TYPE,

2016-2025 (USD MILLION) 176

TABLE 79 CANADA HEMODIALYSIS CONSUMABLES MARKET,BY TYPE,

2016-2025 (USD MILLION) 176

TABLE 80 CANADA HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 177

TABLE 81 CANADA HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 177

TABLE 82 CANADA HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKET

BY TYPE, 2016-2025 (USD MILLION) 178

TABLE 83 CANADA HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 178

TABLE 84 CANADA HEMODIALYSIS SERVICES MARKET, BY TYPE,

2016-2025 (USD MILLION) 179

TABLE 85 CANADA HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 179

TABLE 86 CANADA HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 180

TABLE 87 CANADA HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 180

TABLE 88 CANADA PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2016-2025 (USD MILLION) 181

TABLE 89 CANADA PERITONEAL DIALYSIS CATHETERS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 181

TABLE 90 CANADA PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 182

TABLE 91 CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 182

TABLE 92 CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 183

TABLE 93 MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 184

TABLE 94 MEXICO HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 184

TABLE 95 MEXICO HEMODIALYSIS MACHINE MARKET, BY TYPE,

2016-2025 (USD MILLION) 185

TABLE 96 MEXICO HEMODIALYSIS CONSUMABLES MARKET,BY TYPE,

2016-2025 (USD MILLION) 185

TABLE 97 MEXICO HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 186

TABLE 98 MEXICO HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 186

TABLE 99 MEXICO HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKETBY TYPE, 2016-2025 (USD MILLION) 187

TABLE 100 MEXICO HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 187

TABLE 101 MEXICO HEMODIALYSIS SERVICES MARKET, BY TYPE,

2016-2025 (USD MILLION) 188

TABLE 102 MEXICO HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 188

TABLE 103 MEXICO HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 189

TABLE 104 MEXICO HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 189

TABLE 105 MEXICO PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES,

2016-2025 (USD MILLION) 190

TABLE 106 MEXICO PERITONEAL DIALYSIS CATHETERS MARKET, BY TYPE,

2016-2025 (USD MILLION) 190

TABLE 107 MEXICO PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 191

TABLE 108 MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 191

TABLE 109 MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 192

Licence Rights

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Fresenius

DaVita Inc.

Baxter,

B. Braun Melsungen AG,

Diaverum,

Nipro, Nxstage Medical, Inc.,

Nikkiso Co., Ltd.,

Mar Cor Purification,

Asahi Kasei Medical Co., Ltd,

Rockwell Medical,

Medtronic,

Dialifegroup,

JMS Co.Ltd.,

Atlantic Biomedical,

3M,

Allmed Medical Care Holdings Limited.,

Isopure Corp.,

C. R. Bard, Inc.

North America hemodialysis and peritoneal dialysis market is expected to reach USD 53,741.5 million by 2025 from USD 32,324.9 million in 2017, at a CAGR of 6.7% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

The major factors driving the market are increased number of ESRD patients. The hemodialysis and peritoneal dialysis market in the North America region is leading in U.S.

The key market players for North America hemodialysis and peritoneal dialysis market are listed below:

Fresenius

DaVita Inc.

Baxter,

B. Braun Melsungen AG,

Diaverum,

Nipro, Nxstage Medical, Inc.,

Nikkiso Co., Ltd.,

Mar Cor Purification,

Asahi Kasei Medical Co., Ltd,

Rockwell Medical,

Medtronic,

Dialifegroup,

JMS Co.Ltd.,

Atlantic Biomedical,

3M,

Allmed Medical Care Holdings Limited.,

Isopure Corp.,

C. R. Bard, Inc.

The market is further segmented into:

Type

Products & Services

Modality

Hemodialysis Water Treatment System

End-user

The North America hemodialysis and peritoneal dialysis market is segmented on the basis of type, biopsy technique and end users. The report provides data for 2016 to 2025, 2017 being the current year while 2018 to 2025 is the forecast period for the report.

The North America hemodialysis & peritoneal dialysis market is segmented on the basis of type into hemodialysis and peritoneal dialysis. In 2018, The Hemodialysis Market is expected to dominate the market with 75.2% market share and is expected to reach USD 39,981.6 million by 2025, growing at a CAGR of 6.5% in the forecast period 2018 to 2025.

The North America hemodialysis market is segmented on the basis of product services into machine, consumables, and services. In 2018, the hemodialysis machine market is expected to dominate market with 41.2% market share and is expected to reach USD 16,954.7 million by 2025, growing at a CAGR of 6.9% in the forecast period 2018 to 2025. The machines are further sub segmented into center-use hemodialysis machines and home-use hemodialysis machines. The consumables are further sub segmented into dialyzers, bloodlines, hemodialysis concentrates and others. Dialyzers are further sub-segmented on the basis of material type into synthetic and cellulose based; on the basis of flux type into high-flux and low-flux and on the basis of by hemodialysis access management products into AV fistula, arteriovenous grafts, tunneled hemodialysis catheter and temporary hemodialysis catheter. Hemodialysis concentrates are further sub-segmented into- alkaline and acidic. Services are further sub-segmented into in-center hemodialysis services and home hemodialysis services.

The North America hemodialysis water treatment system Market is segmented on the basis of type into central water disinfection systems and portable water disinfection systems. In 2018, portable water disinfection systems market is expected to dominate market with 60.6% market share and is expected to reach USD 24,784.9 million by 2025, growing at a CAGR of 6.8% in the forecast period 2018 to 2025. Central water disinfection systems are further sub-segmented into chemical disinfection systems, heat disinfection systems, accessories.

The North America hemodialysis market is segmented on the basis of modality into conventional long-term, short daily and nocturnal. In 2018, conventional long-term market is expected to dominate market with 42.1% market share and is expected to reach USD 17,289.5 million by 2025, growing at a CAGR of 6.9% in the forecast period 2018 to 2025.

The North America peritoneal dialysis market is segmented on the basis of products and services into concentrates, machines, catheters, transfer sets, services and others. In 2018, peritoneal machine market is expected to dominate market with 31.2% market share and is expected to reach USD 4,644.8 million by 2025, growing at a CAGR of 8.3% in the forecast period 2018 to 2025. The catheters are further sub-segmented into short-term catheters and long term catheters.

The North America peritoneal dialysis market is segmented on the basis of modality into continuous ambulatory peritoneal dialysis and automated peritoneal dialysis. In 2018, continuous ambulatory dialysis market is expected to dominate market with 67.8% market share and is expected to reach USD 9,478.7 million by 2025, growing at a CAGR of 7.4% in the forecast period 2018 to 2025.

The North America hemodialysis & peritoneal dialysis market is segmented on the basis of end-user into hospitals, dialysis centers and home care settings. In 2018, dialysis centers market is expected to dominate market with 57.6% market share and is expected to reach USD 31,293.7 million by 2025, growing at a CAGR 6.8% in the forecast period 2018 to 2025. The home care settings are further sub-segmented into peritoneal dialysis and home dialysis.

Based on geography, the North America hemodialysis and peritoneal dialysis market is segmented into geographical regions, such as,

U.S.,

Canada

Mexico

Covered in this report

The report covers the present scenario and the growth prospects of the North America hemodialysis and peritoneal dialysis market for 2018-2025. To calculate the market size, the report considers the revenue generated from the sales of the web conferencing and unified communication and collaboration (UC&C) and video conferencing, secondary resources and doing in-depth company share analysis of major 10 players in the market.

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

READ MORE

Scope

Table Of Contents

1. Introduction 50

1.1. Objectives Of The Study 50

1.2. Market Definition 50

1.3. Overview Of North America Hemodialysis & Peritoneal Dialysis Market 50

1.4. Currency And Pricing 51

1.5. Limitation 52

1.6. Markets Covered 52

2. Market Segmentation 55

2.1. Markets Covered 55

2.2. Geographic Scope 56

2.3. Years Considered For The Study 57

2.4. Currency And Pricing 57

2.5. Research Methodology 58

2.6. Primary Interviews With Key Opinion Leaders 61

2.7. Secondary Sources 62

2.8. Assumptions 62

3. Market Overview 63

3.1. Drivers 65

3.1.1. Increased Number Of End Stage Renal Disease (Esrd) Patients 65

3.1.2. Increased Prevalance Of Diabetes And Hypertension 66

3.1.3. Preferance Of Patients For Dialysis Treatment Over Kidney Transplant 67

3.1.4. Rising Geriatric Population 68

3.1.5. R&D Investemnts In For Innovating Dialysis Products 68

3.1.6. Technological Advancements In The Products 70

3.1.7. Favorable Reimbursement Policy 71

3.2. Restraints 72

3.2.1. Risks Associated With The Treatment 72

3.2.2. Stringent Regulatory Framework 73

3.3. Opportunities 74

3.3.1. Increased Demand Of Homecare Settings For Dialysis Treatment 74

3.3.2. Low Cost And User Friendly Products Innovated 75

3.4. Challenges 76

3.4.1. Product Recalls 76

4. Executive Summary 77

5. Premium Insights 81

6. North America Hemodialysis & Peritoneal Dialysis Market, By Type 88

6.1. Overview 89

6.2. Hemodialysis 91

6.3. Peritoneal Dialysis 92

7. North America Hemodialysis Market, By Products And Services 93

7.1. Overview 94

7.2. Machines 96

7.2.1. Center-Use Hemodialysis Machines 98

7.2.2. Home-Use Hemodialysis Machines 98

7.3. Consumables 99

7.3.1. Dialyzers 101

7.3.1.1. Dialyzers Market, By Material Type 101

7.3.1.2. Dialyzers Market, By Flux Type 102

7.3.1.3. Hemodialysis Access Management Products Market, By Type 103

7.3.2. Bloodlines 104

7.3.3. Hemodialysis Concentrates 104

7.3.3.1. Alkaline 105

7.3.3.2. Acidic 105

7.3.4. Others 105

7.4. Services 106

7.4.1. In-Center Hemodialysis Services 107

7.4.2. Home Hemodialysis Services 107

8. North America Hemodialysis Market, By Modality 108

8.1. Overview 109

8.2. Conventional Long-Term 111

8.3. Nocturnal 112

8.4. Short Daily 113

9. North America Peritoneal Market, By Products And Services 114

9.1. Overview 115

9.2. Machines 117

9.3. Catheters 118

9.3.1. Short Term Catheters 119

9.3.2. Long Term Catheters 119

9.4. Transfer Sets 120

9.5. Concentrates 121

9.6. Services 122

9.7. Others 123

10. North America Peritoneal Dialysis Market, By Modality 124

10.1. Overview 125

10.2. Continuous Ambulatory Peritoneal Dialysis 127

10.3. Automated Peritoneal Dialysis 128

11. North America Hemodialysis Water Treatment Systems Market,

By Type 129

11.1. Overview 130

11.2. Portable Water Disinfection Systems 132

11.3. Central Water Disinfection Systems 133

11.3.1. Heat Disinfection Systems 134

11.3.2. Chemical Disinfection Systems 135

11.3.3. Accessories 135

12. North America Hemodialysis And Peritoneal Dialysis Market,

By End User 136

12.1. Overview 137

12.2. Dialysis Centers 139

12.3. Hospitals 140

12.4. Home Care Settings 141

12.4.1. Peritoneal Dialysis 142

12.4.2. Home Hemodialysis 142

13. North America Hemodialysis And Peritoneal Dialysis Market,

By Geography 143

13.1. Overview 144

13.2. North America 151

13.2.1. U.S. 166

13.2.2. Canada 175

13.2.3. Mexico 184

14. North America Hemodialysis And Peritoneal Dialysis Market, Company Landscape 457

14.2. Company Share Analysis: North America 458

15. Company Profile 461

15.1. Davita Inc. 461

15.1.1. Company Overview 461

15.1.2. Davita, Inc.: Revenue Analysis 462

15.1.3. Product Portfolio 463

15.1.4. Recent Developments 464

15.2. Diaverum 465

15.2.1. Company Overview 465

15.2.2. Diaverum: Company Snapshot 465

15.2.3. Product Portfolio 466

15.2.4. Recent Developments 466

15.3. Nipro 467

15.3.1. Company Overview 467

15.3.2. Nipro Corporation: Revenue Analysis 468

15.3.3. Product Portfolio 469

15.3.4. Recent Developments 470

15.4. Nxstage Medical, Inc. 471

15.4.1. Company Overview 471

15.4.2. Nxstage Medical, Inc.: Company Snapshot 472

15.4.3. Product Portfolio 473

15.4.4. Recent Developments 474

15.5. Nikkiso Co., Ltd. 476

15.5.1. Company Overview 476

15.5.2. Nikkiso Co., Ltd.: Revenue Analysis 477

15.5.3. Product Portfolio 478

15.5.4. Recent Developments 478

15.6. Atlantic Biomedical Pvt. Ltd 479

15.6.1. Company Overview 479

15.6.2. Atlantic Biomedical Pvt. Ltd: Company Snapshot 479

15.6.3. Product Portfolio 480

15.6.4. Recent Developments 480

15.7. 3M 481

15.7.1. Company Overview 481

15.7.2. 3M: Company Snapshot 481

15.7.3. Product Portfolio 482

15.7.4. Recent Developments 482

15.8. C.R. Bard Inc. 483

15.8.1. Company Overview 483

15.8.2. C. R. Bard Inc.: Revenue Analyses 483

15.8.3. Product Portfolio 484

15.8.4. Recent Developments 484

15.9. Allmed Medical Co., Limited 485

15.9.1. Company Overview 485

15.9.2. Allmed Medical Co., Ltd: Company Snapshot 485

15.9.3. Product Portfolio 486

15.9.4. Recent Developments 486

15.10. Isopure Corp. 487

15.10.1. Company Overview 487

15.10.2. Isopure Corp : Company Snapshot 487

15.10.3. Product Portfolio 488

15.10.4. Recent Developments 488

15.11. Cvp Medical Technology Co., Ltd 489

15.11.1. Company Overview 489

15.11.2. Cvp Medical Technology Co., Ltd.: Company Snapshot 489

15.11.3. Product Portfolio 490

15.11.4. Recent Developments 490

15.12. Mar Cor Purification Inc. 491

15.12.1. Company Overview 491

15.12.2. Mar Cor Purification: Company Snapshot 491

15.12.3. Product Portfolio 492

15.12.4. Recent Developments 494

15.13. Baxter 495

15.13.1. Company Overview 495

15.13.2. Baxter: Company Snapshot 495

15.13.3. Product Portfolio 496

15.13.4. Recent Developments 497

15.14. Medtronic 498

15.14.1. Company Overview 498

15.14.2. Medtronic: Rvenue Analysis 498

15.14.3. Product Portfolio 499

15.14.4. Recent Developments 499

15.15. Fresenius Group 500

15.15.1. Company Overview 500

15.15.2. Fresenius Group: Revenue Analysis 500

15.15.3. Product Portfolio 501

15.15.4. Recent Developments 502

15.16. B.Braun 503

15.16.1. Company Overview 503

15.16.2. B.Braun.: Company Snapshot 503

15.16.3. Product Portfolio 504

15.16.4. Recent Developments 504

15.17. Asahi Kasei Corporation 505

15.17.1. Company Overview 505

15.17.2. Asahi Kasei Corporation: Revenue Analysis 506

15.17.3. Product Portfolio 506

15.17.4. Recent Developments 507

15.18. Rockwell Medical, Inc. 508

15.18.1. Company Overview 508

15.18.2. Rockwell Medical, Inc.: Revenue Analysis 508

15.18.3. Product Portfolio 508

15.18.4. Recent Developments 509

15.19. Dialife Group 510

15.19.1. Company Overview 510

15.19.2. Dialife Group: Company Snapshot 510

15.19.3. Product Portfolio 511

15.19.4. Recent Developments 511

15.20. Jms Co., Ltd. 512

15.20.1. Company Overview 512

15.20.2. Jms Co., Ltd.: Company Snapshot 512

15.20.3. Product Portfolio 512

15.20.4. Recent Developments 513

16. Related Reports 515


List Of Figure

Figures List

Figure 1 North America Hemodialysis & Peritoneal Dialysis Market : Segmentation 55

Figure 2 North America Hemodialysis & Peritoneal Dialysis Market :

Data Triangulation 58

Figure 3 North America Hemodialysis & Peritoneal Dialysis Market :

Research Snapshot 59

Figure 4 North America Hemodialysis & Peritoneal Dialysis Market :

Bottom Up Approach 60

Figure 5 North America Hemodialysis & Peritoneal Dialysis Market :

Top Down Approach 60

Figure 6 North America Hemodialysis & Peritoneal Dialysis Market :

Interview Demographics 61

Figure 7 Drivers, Restraints, Opportunities, And Challenges Of

North America Hemodialysis & Peritoneal Dialysis Market 64

Figure 8 North America Hemodialysis & Peritoneal Dialysis Market : Segmentation 79

Figure 9 North America Is Expected To Dominate The Market For Hemodialysis & Peritoneal Dialysis And Asia Pacific Is Expected To Be Growing With The Highest Cagr In The Forecast Period From 2018 To 2025 80

Figure 10 Increasing Number Of Esrd Patients Are The Factors And R&D Investments For Innovating Dialysis Products Are Expected To Drive The Market For Hemodialysis & Peritoneal Dialysis Market In The Forecast Period 2018 To 2025 81

Figure 11 Hemodialysis Is Expected To Account For The Largest Share Of The North America Hemodialysis & Peritoneal Dialysis Market In 2018 & 2025 82

Figure 12 Asia Pacific Is The Highest Growing And Most Profitable Revenue Pockets For Hemodialysis And Peritoneal Dialysis Manufacturers In The Forecast Period From 2018 To 2025 83

Figure 13 Diabetes Prevalence In Different Countries In 2017 (% Of Population Ages Between 20 To 79) 84

Figure 14 Prevalent Counts Of Reported Esrd In U.S. (2001-2015) 85

Figure 15 Various Causes Of Esrd In U.S. (2010 & 2015) 86

Figure 16 Number Of Diabetic Patients, By Region In 2017 (Million) 87

Figure 17 North America Hemodialysis & Peritoneal Dialysis Market: By Type, 2017 89

Figure 18 North America Hemodialysis Market : By Products & Services, 2017 94

Figure 19 North America Hemodialysis Market: By Modality, 2017 109

Figure 29 North America Hemodialysis And Peritoneal Dialysis Market : Snapshot (2017) 152

Figure 30 North America Hemodialysis And Peritoneal Dialysis Market:

By Country (2017) 153

Figure 31 North America Hemodialysis And Peritoneal Dialysis Market:

By Country (2018) 154

Figure 32 North America Hemodialysis And Peritoneal Dialysis Market,

By Country (2017 & 2025) 155

Figure 33 North America Hemodialysis And Peritoneal Dialysis Market,

By Product Type (2018 & 2025) 156

Figure 55 North America Hemodialysis And Peritoneal Dialysis Market: Company Share 2017 (%) 458


List Of Table

TABLE 1 FRESENIUS MEDICAL CARE AG & CO. KGAA, R&D ACTIVITIES 69

TABLE 2 DAVITA INC.: GROWTH OF U.S. DIALYSIS OPERATIONS BY NUMBER OF DIALYSIS CENTERS 69

TABLE 3 NORTH AMERICA HEMODIALYSIS & PERITONEAL DIALYSIS MARKET, BY TYPE,

2016-2025 (USD MILLION) 90

TABLE 4 NORTH AMERICA HEMODIALYSIS MARKET, BY REGION, 2016-2025 (USD MILLION) 91

TABLE 5 NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY REGION,

2016-2025 (USD MILLION) 92

TABLE 6 NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCTS & SERVICES,

2016-2025 (USD MILLION) 95

TABLE 7 NORTH AMERICA HEMODIALYSIS, MACHINES MARKET, BY TYPE

2016-2025 (USD MILLION) 96

TABLE 8 NORTH AMERICA HEMODIALYSIS MACHINES MARKET, BY REGION,

2016-2025 (USD MILLION) 97

TABLE 9 NORTH AMERICA HEMODIALYSIS CONSUMABLES MARKET, BY TYPE,

2016-2025 (USD MILLION) 99

TABLE 10 NORTH AMERICA HEMODIALYSIS CONSUMABLES MARKET, BY REGION,

2016-2025 (USD MILLION) 100

TABLE 11 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 101

TABLE 12 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 102

TABLE 13 NORTH AMERICA HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 104

TABLE 14 NORTH AMERICA HEMODIALYSIS SERVICES MARKET, BY TYPE,

2016-2025 (USD MILLION) 106

TABLE 15 NORTH AMERICA HEMODIALYSIS SERVICES MARKET, BY REGION,

2016-2025 (USD MILLION) 107

TABLE 16 NORTH AMERICA HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 110

TABLE 17 NORTH AMERICA CONVENTIONAL LONG-TERM HEMODIALYSIS MARKET, BY REGION, 2016-2025 (USD MILLION) 111

TABLE 18 NORTH AMERICA NOCTURNAL HEMODIALYSIS MARKET , BY REGION,

2016-2025 (USD MILLION) 112

TABLE 19 NORTH AMERICA SHORT DAILY HEMODIALYSIS MARKET, BY REGION,

2016-2025 (USD MILLION) 113

TABLE 41 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY COUNTRY, 2016-2025 (USD MILLION) 157

TABLE 42 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 157

TABLE 43 NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 158

TABLE 44 NORTH AMERICA HEMODIALYSIS MACHINE MARKET, BY TYPE,

2016-2025 (USD MILLION) 158

TABLE 45 NORTH AMERICA HEMODIALYSIS CONSUMABLES MARKET, BY TYPE,

2016-2025 (USD MILLION) 159

TABLE 46 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET,

BY MATERIAL TYPE, 2016-2025 (USD MILLION) 159

TABLE 47 NORTH AMERICA HEMODIALYSIS DIALYZERS MARKET,

BY FLUX TYPE, 2016-2025 (USD MILLION) 160

TABLE 48 NORTH AMERICA HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKETBY TYPE, 2016-2025 (USD MILLION) 160

TABLE 49 NORTH AMERICA HEMODIALYSIS CONCENTRATES MARKET,

BY TYPE, 2016-2025 (USD MILLION) 161

TABLE 50 NORTH AMERICA HEMODIALYSIS SERVICES MARKET,

BY TYPE, 2016-2025 (USD MILLION) 161

TABLE 51 NORTH AMERICA HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 162

TABLE 52 NORTH AMERICA HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 162

TABLE 53 NORTH AMERICA HEMODIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 163

TABLE 54 NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2016-2025 (USD MILLION) 163

TABLE 55 NORTH AMERICA PERITONEAL DIALYSIS CATHETERS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 164

TABLE 56 NORTH AMERICA PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 164

TABLE 57 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 165

TABLE 58 NORTH AMERICA HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 165

TABLE 59 U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 166

TABLE 60 U.S. HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 166

TABLE 61 U.S. HEMODIALYSIS MACHINE MARKET, BY TYPE, 2016-2025 (USD MILLION) 167

TABLE 62 U.S. HEMODIALYSIS CONSUMABLES MARKET,BY TYPE,

2016-2025 (USD MILLION) 167

TABLE 63 U.S. HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 168

TABLE 64 U.S. HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 168

TABLE 65 U.S. HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKET

BY TYPE, 2016-2025 (USD MILLION) 169

TABLE 66 U.S. HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 169

TABLE 67 U.S. HEMODIALYSIS SERVICES MARKET, BY TYPE, 2016-2025 (USD MILLION) 170

TABLE 68 U.S. HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 170

TABLE 69 U.S. HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 171

TABLE 70 U.S. HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 171

TABLE 71 U.S. PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES,

2016-2025 (USD MILLION) 172

TABLE 72 U.S. PERITONEAL DIALYSIS CATHETERS MARKET, , BY TYPE,

2016-2025 (USD MILLION) 172

TABLE 73 U.S. PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 173

TABLE 74 U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 173

TABLE 75 U.S. HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 174

TABLE 76 CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 175

TABLE 77 CANADA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 175

TABLE 78 CANADA HEMODIALYSIS MACHINE MARKET, BY TYPE,

2016-2025 (USD MILLION) 176

TABLE 79 CANADA HEMODIALYSIS CONSUMABLES MARKET,BY TYPE,

2016-2025 (USD MILLION) 176

TABLE 80 CANADA HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 177

TABLE 81 CANADA HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 177

TABLE 82 CANADA HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKET

BY TYPE, 2016-2025 (USD MILLION) 178

TABLE 83 CANADA HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 178

TABLE 84 CANADA HEMODIALYSIS SERVICES MARKET, BY TYPE,

2016-2025 (USD MILLION) 179

TABLE 85 CANADA HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 179

TABLE 86 CANADA HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 180

TABLE 87 CANADA HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 180

TABLE 88 CANADA PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2016-2025 (USD MILLION) 181

TABLE 89 CANADA PERITONEAL DIALYSIS CATHETERS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 181

TABLE 90 CANADA PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 182

TABLE 91 CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 182

TABLE 92 CANADA HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 183

TABLE 93 MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 184

TABLE 94 MEXICO HEMODIALYSIS MARKET, BY PRODUCT AND SERVICES,

2016-2025 (USD MILLION) 184

TABLE 95 MEXICO HEMODIALYSIS MACHINE MARKET, BY TYPE,

2016-2025 (USD MILLION) 185

TABLE 96 MEXICO HEMODIALYSIS CONSUMABLES MARKET,BY TYPE,

2016-2025 (USD MILLION) 185

TABLE 97 MEXICO HEMODIALYSIS DIALYZERS MARKET, BY MATERIAL TYPE,

2016-2025 (USD MILLION) 186

TABLE 98 MEXICO HEMODIALYSIS DIALYZERS MARKET, BY FLUX TYPE,

2016-2025 (USD MILLION) 186

TABLE 99 MEXICO HEMODIALYSIS ACCESS MANAGEMENT PRODUCTS MARKETBY TYPE, 2016-2025 (USD MILLION) 187

TABLE 100 MEXICO HEMODIALYSIS CONCENTRATES MARKET, BY TYPE,

2016-2025 (USD MILLION) 187

TABLE 101 MEXICO HEMODIALYSIS SERVICES MARKET, BY TYPE,

2016-2025 (USD MILLION) 188

TABLE 102 MEXICO HEMODIALYSIS WATER TRATMENT SYSTEMS MARKET,

BY TYPE, 2016-2025 (USD MILLION) 188

TABLE 103 MEXICO HEMODIALYSIS CENTRAL WATER DISINFECTION MARKET,

BY TYPE, 2016-2025 (USD MILLION) 189

TABLE 104 MEXICO HEMODIALYSIS MARKET, BY MODALITY, 2016-2025 (USD MILLION) 189

TABLE 105 MEXICO PERITONEAL DIALYSIS MARKET, BY PRODUCTS AND SERVICES,

2016-2025 (USD MILLION) 190

TABLE 106 MEXICO PERITONEAL DIALYSIS CATHETERS MARKET, BY TYPE,

2016-2025 (USD MILLION) 190

TABLE 107 MEXICO PERITONEAL DIALYSIS MARKET, BY MODALITY,

2016-2025 (USD MILLION) 191

TABLE 108 MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS MARKET,

BY END USER, 2016-2025 (USD MILLION) 191

TABLE 109 MEXICO HEMODIALYSIS AND PERITONEAL DIALYSIS HOME CARE SETTINGS MARKET, BY TYPE, 2016-2025 (USD MILLION) 192

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Companies

Fresenius

DaVita Inc.

Baxter,

B. Braun Melsungen AG,

Diaverum,

Nipro, Nxstage Medical, Inc.,

Nikkiso Co., Ltd.,

Mar Cor Purification,

Asahi Kasei Medical Co., Ltd,

Rockwell Medical,

Medtronic,

Dialifegroup,

JMS Co.Ltd.,

Atlantic Biomedical,

3M,

Allmed Medical Care Holdings Limited.,

Isopure Corp.,

C. R. Bard, Inc.